Phibro Animal Health CorporationPAHCNASDAQ
Loading
Net Income Growth Under PressureDecelerating
Percentile Rank54
3Y CAGR-65.7%
5Y CAGR-2.8%
Year-over-Year Change
Year-over-year net income growth rate
3Y CAGR
-65.7%/yr
Quarterly compound
5Y CAGR
-2.8%/yr
Recent deceleration
Percentile
P54
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.51% |
| Q3 2025 | 54.01% |
| Q2 2025 | -17.51% |
| Q1 2025 | 555.57% |
| Q4 2024 | -54.34% |
| Q3 2024 | 827.53% |
| Q2 2024 | -91.05% |
| Q1 2024 | 559.73% |
| Q4 2023 | 115.90% |
| Q3 2023 | -169.71% |
| Q2 2023 | 14.50% |
| Q1 2023 | 39.28% |
| Q4 2022 | 86.98% |
| Q3 2022 | -48.50% |
| Q2 2022 | -57.67% |
| Q1 2022 | 1.28% |
| Q4 2021 | 167.29% |
| Q3 2021 | -61.84% |
| Q2 2021 | 40.79% |
| Q1 2021 | -5.00% |
| Q4 2020 | 4.06% |
| Q3 2020 | 118.04% |
| Q2 2020 | -58.21% |
| Q1 2020 | 13.51% |
| Q4 2019 | 372.92% |
| Q3 2019 | -71.42% |
| Q2 2019 | -40.74% |
| Q1 2019 | 0.68% |
| Q4 2018 | -9.60% |
| Q3 2018 | -26.18% |
| Q2 2018 | 11.39% |
| Q1 2018 | 182.14% |
| Q4 2017 | -55.75% |
| Q3 2017 | 3.19% |
| Q2 2017 | -34.86% |
| Q1 2017 | 76.22% |
| Q4 2016 | 10.18% |
| Q3 2016 | -19.89% |
| Q2 2016 | -18.18% |
| Q1 2016 | -38.44% |